5.13
price down icon0.19%   -0.010
after-market After Hours: 5.31 0.18 +3.51%
loading
Sana Biotechnology Inc stock is traded at $5.13, with a volume of 6.56M. It is down -0.19% in the last 24 hours and up +72.73% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$5.14
Open:
$5.25
24h Volume:
6.56M
Relative Volume:
1.46
Market Cap:
$1.16B
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-3.4898
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
+15.28%
1M Performance:
+72.73%
6M Performance:
+51.78%
1Y Performance:
-16.18%
1-Day Range:
Value
$5.05
$5.33
1-Week Range:
Value
$4.165
$5.33
52-Week Range:
Value
$1.26
$7.30

Sana Biotechnology Inc Stock (SANA) Company Profile

Name
Name
Sana Biotechnology Inc
Name
Phone
(206) 701-7914
Name
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Name
Employee
194
Name
Twitter
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
SANA's Discussions on Twitter

Compare SANA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SANA
Sana Biotechnology Inc
5.13 1.16B 0 -283.26M -273.61M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-03-25 Resumed Morgan Stanley Overweight
Mar-18-25 Upgrade Citizens JMP Mkt Perform → Mkt Outperform
Mar-14-25 Initiated Jefferies Buy
Jan-08-25 Upgrade TD Cowen Hold → Buy
Nov-05-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-26-24 Initiated Rodman & Renshaw Buy
Jan-16-24 Upgrade H.C. Wainwright Neutral → Buy
Sep-25-23 Initiated JMP Securities Mkt Outperform
Sep-05-23 Initiated Citigroup Buy
Aug-14-23 Initiated TD Cowen Market Perform
May-02-23 Initiated H.C. Wainwright Neutral
Mar-01-21 Initiated BofA Securities Buy
Mar-01-21 Initiated Goldman Neutral
Mar-01-21 Initiated JP Morgan Neutral
Mar-01-21 Initiated Morgan Stanley Overweight
View All

Sana Biotechnology Inc Stock (SANA) Latest News

pulisher
Jul 23, 2025

What analysts say about Sana Biotechnology Inc. stockExplosive portfolio gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Sana Biotechnology Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Sana Biotechnology Inc. a good long term investmentFree Stock Chart Pattern Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025
pulisher
Jul 22, 2025

Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results - MSN

Jul 22, 2025
pulisher
Jul 21, 2025

Commit To Purchase Sana Biotechnology At $2.50, Earn 28% Using Options - Nasdaq

Jul 21, 2025
pulisher
Jul 19, 2025

What drives Sana Biotechnology Inc. stock priceMassive profits - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors - GlobeNewswire Inc.

Jul 15, 2025
pulisher
Jul 14, 2025

How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga

Jul 14, 2025
pulisher
Jul 13, 2025

Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Sana Biotechnology: A Stem Cell Breakthrough at the Crossroads of Risk and Reward - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Sana Biotechnology (SANA) Soars 4.11% on Positive Diabetes Data - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN

Jul 08, 2025
pulisher
Jul 07, 2025

Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges - Investing.com

Jul 07, 2025
pulisher
Jul 06, 2025

Sana Biotechnology's 9% Spike: Technical Signals and Peer Dynamics Drive Unusual Intraday Rally - AInvest

Jul 06, 2025
pulisher
Jul 06, 2025

Sana Biotechnology (SANA.O) Surges 9% Amid Technical Bullish Signal: What’s Driving the Move? - AInvest

Jul 06, 2025
pulisher
Jul 06, 2025

Sana Biotechnology's 9% Surge: Technical Bullishness or Biotech Momentum? - AInvest

Jul 06, 2025
pulisher
Jul 05, 2025

Sana Biotechnology's 9% Surge: Technical Bullish Signal or Sector Shift? - AInvest

Jul 05, 2025
pulisher
Jul 04, 2025

Sana Biotechnology’s 9% Surge: Technical Catalysts and Peer Dynamics - AInvest

Jul 04, 2025
pulisher
Jul 04, 2025

Sana Biotechnology's 9% Surge: Technicals or a Hidden Catalyst? - AInvest

Jul 04, 2025
pulisher
Jul 04, 2025

Sana Biotechnology's 9% Spike: A Technical Catalyst Amid Mixed Biotech Sentiment - AInvest

Jul 04, 2025
pulisher
Jul 04, 2025

Sana Biotechnology's 9% Surge: Technical Catalysts and Market Dynamics - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

Morgan Stanley Assigns Overweight Rating to Sana Biotechnology with $12 Price Target - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Sana Biotechnology assumed with an Overweight at Morgan Stanley - TipRanks

Jul 02, 2025
pulisher
Jun 30, 2025

Top 10 CRISPR Stocks to Buy Now - Insider Monkey

Jun 30, 2025
pulisher
Jun 30, 2025

Sana Biotechnology, Inc.(NasdaqGS: SANA) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Sana Biotechnology (SANA) Receives a Buy from Citizens JMP - The Globe and Mail

Jun 25, 2025
pulisher
Jun 24, 2025

BofA Remains Bullish on Sana Biotechnology (SANA) - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Sana Biotechnology's HIP-Engineered Cell Therapy: A Diabetes Cure With Multi-Bagger Potential? - AInvest

Jun 23, 2025
pulisher
Jun 18, 2025

SANA Stock on the Rise: A Promising Investment - investchronicle.com

Jun 18, 2025
pulisher
Jun 16, 2025

Investigation announced for long-term Investors in shares - openPR.com

Jun 16, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Makes New $29,000 Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Sana Biotechnology (NASDAQ:SANA) versus Mosaic ImmunoEngineering (OTCMKTS:CPMV) Critical Analysis - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 25,383 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Lead Plaintiff Appointed in Sana Biotechnology Class Action — Here’s How You Can Recover Your Losses - TradingView

Jun 11, 2025
pulisher
Jun 11, 2025

Paysign Leads Our Trio Of Penny Stock Highlights - simplywall.st

Jun 11, 2025

Sana Biotechnology Inc Stock (SANA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Sana Biotechnology Inc Stock (SANA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Cassidy Bernard J
EVP & General Counsel
Mar 07 '25
Option Exercise
0.00
11,041
0
115,823
Harr Steve
President & CEO
Mar 07 '25
Option Exercise
0.00
50,000
0
7,889,750
Wyrick Susan D.
See Remarks
Mar 02 '25
Option Exercise
0.00
1,525
0
155,471
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Cap:     |  Volume (24h):